Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
09/24/09 - Class 424 site info News monitor Monitor Keywords monitor archive Archive organizer Organizer account info Account |  424 rss/xml feed | Prev - Next

Diagnostic therapeutic method

Abstract: wherein R represents an average grain size of the magnetic vesicular particles and r represents an average particle size of magnetic microparticles included in the magnetic vesicular particles. 0.05≦R/(r×100)≦1.5 A pharmaceutical preparation containing magnetic vesicular particles is disclosed, wherein the magnetic vesicular particles each include magnetic microparticles within a lipid membrane, an organic compound having at least two groups selected from the group consisting of a hydroxyl group, a carboxyl group, a carbamoyl group, an amino group, a mercapto group, a sulfo group, a dithio group, a thiocarboxyl group and a dithiocarboxyl group is bonded to the magnetic microparticle, and the magnetic vesicular particles satisfy the following equation: (end of abstract)


Agent: Lucas & Mercanti, LLP - New York, NY, US
Inventor: Toshihisa TAKEYAMA
USPTO Applicaton #: #20090238764 - Class: 424 93 (USPTO)

Diagnostic therapeutic method description/claims


The Patent Description & Claims data below is from USPTO Patent Application 20090238764, Diagnostic therapeutic method.

Full Patent Description - Patent Application Claims  monitor keywords

This Application is a Divisional of U.S. patent application Ser. No. 11/924,961 filed Oct. 26, 2007, pending, which was a Divisional of U.S. patent application Ser. No. 11/268,213 filed Nov. 7, 2005, now U.S. Pat. No. 7,427,393 which, in turn, claimed the priority of Japanese Patent Application No. JP2004-326431, filed on Nov. 10, 2004, all three applications are incorporated herein by reference.

FIELD OF THE INVENTION

The present invention relates to pharmaceutical preparations containing magnetic vesicular particles in which magnetic microparticles are bonded with an organic compound, and a manufacturing method thereof, and a diagnostic therapeutic system

BACKGROUND OF THE INVENTION

Development of “magnetic nano-beads” has been promoted as one of promising medical materials for use in next generation medical techniques. The magnetic nano-beads (hereinafter, also denoted as magnetic microparticles) are nano-level size microparticles of ferrite (solid solution of Fe3O4 and γ-Fe2O3). Recently, there has been developed a technique of synthesizing them under mild conditions of 4 to 25° C. in the range of a neutral pH, as described in JP-A No. 2002-128523 (hereinafter, the term, JP-A refers to Japanese Patent Application Publication). Magnetic nano-beads for medical use have been proposed, in which drugs or physiologically active materials are allowed to be fixed onto (attached to or included in) the magnetic microparticles covered with dextran, lipid, liposome, polymer or the like, as described in JP-A Nos. 2002-128523 and 9-110722. As application of such magnetic microparticles in the medical field are proposed applications to contrast medium material used for MRI diagnosis or a medicine-transporting carrier, and thermotherapy employing heat generation due to hysteresis loss of magnetic microparticles in the high frequency magnetic field; there was further proposed concurrent performance of diagnosis and therapy of cancer by the combination of both of the foregoing, as described in “BIO INDUSTRY” vol. 21, No. 8, page 48-54 (2004).

Thermotherapy for cancer (Hyperthermia) has been proposed for several decades and is one of the cancer therapies studied. The principle of therapy employs a property of cancer cells being weaker to heat than normal cells, thereby giving therapy with artificially maintaining a high temperature environment. Thermotherapy for cancer is a non-invasive treatment as compared to surgical removal operation which is generally conducted for cancer therapy. Comparing to chemotherapy or radiotherapy which often results in adverse effects, it is selective and its adverse effect becomes lower. Thus, it is a treatment which makes preservation of organs feasible and enhances the patient\'s quality of life. It is therefore a treatment suitable for an early cancer, or aged persons or infants who are intolerable to operative invasion or adverse effects. Conventional thermotherapy has employed techniques such as induction heating or focused ultrasonic heating and a recent alternant magnetic field heating using a ferrite type MRI contrast medium, and each of these therapies has merits and demerits. Accordingly, there is studied the possibility of using the above-described ferrite type particles as a novel heat-generating element in the alternating magnetic field, as described in “BIO INDUSTRY” vol. 21, No. 8, page 48-54 (2004).

Feasibility of putting employment of magnetic microparticles into practice in the medical field relies on capability of maintaining a physiologically active material, a treatment drug or the like within the beads or capability of its selective delivery to an intended site (targeting capability). In this regard, the magnetic vesicular particles which have been proposed so far, still leave room for improvement. In enclosure of magnetic microparticles within liposome vesicles, various problems relating preparation of the liposome, for example, residue of organic solvents and stability of a liposome structure retard its practical use.

SUMMARY OF THE INVENTION

It is an object of the present invention to provide a pharmaceutical preparation containing magnetic vesicular particles which enables selective delivery of agents to a tumor site (targeting capability), is applicable to a contrast medium material or drug transport carrier and is also usable in thermotherapy employing heat-generation, and diagnosis and treatment of cancer by the combination thereof, and a manufacturing method thereof and a diagnostic therapeutic system by use thereof.

One aspect of the invention is directed to a pharmaceutical preparation comprising magnetic vesicular particles, wherein the magnetic vesicular particles each include one or more magnetic microparticles within a lipid membrane, the magnetic microparticles are each bonded to an organic compound having in its molecule at least two bonding groups selected from a hydroxyl group, a carboxyl group, a carbamoyl group, an amino group, a mercapto group, a sulfo group, a dithio group, a thiocarboxyl group and a dithiocarboxyl group, and the magnetic vesicular particles satisfy the following equation:



Full Patent Description - Patent Application Claims
Click on the above for other options relating to this Diagnostic therapeutic method patent application.
###
monitor keywords

Other recent patent applications listed under the agent Lucas & Mercanti, LLP:

20090320673 - Gun barrel
20090321209 - Hydraulic arrangement for controlling a twin-clutch transmission of a motor vehicle
20090322286 - Energy source
20090322857 - Continuous adjustable 3deeps filter spectacles for optimized 3deeps stereoscopic viewing and its control method and means
20090322861 - Continuous adjustable 3deeps filter spectacles for optimized 3deeps stereoscopic viewing and its control method and means
20090324146 - Linear guide unit
20090324750 - Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
20090324774 - Method for feeding mother pig
20090325748 - Oil supply system for supplying oil to slide rails and guide rails
20090325814 - Biomolecule detection reagent and method for detecting biomolecule using the same
20090314237 - Switchable bucket tappet
20090314396 - Method for efficient heat treatment of steel
20090314735 - Inflatable container for feeding babies
20090317030 - Angular contact roller bearings, in particular multi-row ball roller bearings
20090317031 - Roller bearing unit and gas control valve arrangement comprising a roller bearing unit
20090317374 - Composition containing arazyme for the prevention and treatment of cancer
20090317498 - Composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response
20090317765 - Supraosseous dental implant
20090317822 - Selection of intracellular immunoglobulins
20090317849 - Biochip for the detection of phosphorylation and the detection method using the same
20090318538 - Polymeric oligonucleotide prodrugs
20090308162 - Method for testing a bearing component by means of ultrasound and optical inspection
20090310898 - Method for producing a rolling bearing component and rolling bearing component
20090311354 - Composition comprising extracts or fractions of magnolia obovata thunb for treating and preventing inflammation disease
20090311621 - Support for planographic printing plate material, manufacturing method thereof, and planographic printing plate material employing the same
20090312286 - Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
20090312421 - Gel useful for the delivery of cosmetic active ingredients
20090312741 - Bioresorbable composition and a medical device comprising said composition
20090301290 - Personal protection apparatus for vehicles
20090301336 - Camouflage and decoy munitions for protecting objects against guided missiles
20090302745 - Organic electroluminescence element material, organic electroluminescence element, display device and lighting apparatus
20090303029 - Continuous enhanced vehicle hazard warning lights
20090304317 - Bearing cage
20090304320 - Radial cylinder roller bearing
20090305828 - Traction mechanism drive for an internal combustion engine
20090306078 - Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
20090306361 - Process for producing cellulose ester film, cellulose ester film, polarization plate and display unit
20090306451 - Process for the treatment of phosphogypsum and in particular of phosphogypsum leachates
20090293904 - Method for making a composite item comprising a cosmetic product and an ornamental element
20090294063 - Plasma processing apparatus
20090297085 - Bearing arrangement of a shaft
20090297292 - Screw fastener
20090297373 - Cooling airflow electric motor-driven pump
20090297670 - Sweetener compositions
20090297972 - Image forming method


How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Diagnostic therapeutic method or other areas of interest.
###


Previous Patent Application:
Method for treating joint damage
Next Patent Application:
Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the Diagnostic therapeutic method patent info.
AAPL - Apple, BA - Boeing, CALP, DTV - Direct TV, EBAY, FRX, GOOG - Google, HEPH, IBM, JBL - Jabil, KO - Coca Cola, LXRX, MOT - Motorla IP-related news and info


Results in 2.38855 seconds


Other interesting Feshpatents.com categories:
Software:  Finance AI Databases Development Document Navigation Error paws
PATENT INFO
About this Page
noimage